Approval · Notice of Compliance 11023 · 2010
HYDROXYUREA: Notice of Compliance 11023
Issued February 8, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11023
- Date
- February 8, 2010
- Company
- Sanis Health Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Antineoplastic agent
- Canadian reference product
- HYDREA
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HYDROXYUREA | 02343096 | Cancelled Post Market |
Medicinal ingredients
- HYDROXYUREA 500 MG per CAP